Skip to main content

Table 2 Correlation between clinicopathological features and expression of TAZ in retinoblastoma patients

From: High expression of TAZ indicates a poor prognosis in retinoblastoma

Feature

All patients n = 43, n (%)

Expression of TAZ

P value

High

Low

Age at presentation (y)

 

28

15

0.602

  < 5 y

39 (90.7)

26

13

 

  ≥ 5 y

4 (9.3)

2

2

 

Gender

 

28

15

0.338

 Male

18 (41.9)

10

8

 

 Female

25 (58.1)

18

7

 

Tumor enucleated location

 

28

15

1.000

 Right

25 (58.1)

16

9

 

 Left

18 (41.9)

12

6

 

cTNM classification

 

T classification

 

28

15

0.116

 T1 + 2

24

13

11

 

 T3 + 4

19

15

4

 

N classification

 

28

15

0.013*

 N0

20

9

11

 

 N1 + 2

23

19

4

 

cTNM stage

 

28

15

0.184

 I + II

14

7

7

 

 III + IV

29

21

8

 

Largest tumor base (mm)

 

28

15

0.045*

  ≤ 15 mm

28 (65.1)

15

13

 

  > 15 mm

15 (34.9)

13

2

 

Tumor thickness (mm)

 

28

15

0.750

  ≤ 10 mm

25 (58.1)

17

8

 

  > 10 mm

18 (41.9)

11

7

 

Differentiation

 

28

15

0.019*

 Well and moderate

24 (55.8)

12

12

 

 Poorly

19 (44.2)

16

3

 
  1. *P < 0.05